Hypomania and mania related to dopamine replacement therapy in Parkinson's disease

被引:28
|
作者
Maier, Franziska [1 ]
Merkl, Josuah [1 ]
Ellereit, Anna L. [1 ]
Lewis, Catharine J. [1 ]
Eggers, Carsten [1 ]
Pedrosa, David J. [1 ]
Kalbe, Elke [1 ,2 ]
Kuhn, Jens [3 ]
Meyer, Thomas D. [4 ]
Zurowski, Mateusz [5 ]
Timmermann, Lars [1 ]
机构
[1] Univ Cologne, Dept Neurol, D-50931 Cologne, Germany
[2] Univ Vechta, Inst Gerontol, Vechta, Germany
[3] Univ Cologne, Dept Psychiat & Psychotherapy, D-50931 Cologne, Germany
[4] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[5] Univ Toronto, Dept Psychiat, Univ Hlth Network, Toronto, ON, Canada
关键词
Parkinson's disease; Dopamine replacement therapy; Hypomania; Mania; Dopamine dysregulation; Impulse control disorders; DEEP BRAIN-STIMULATION; IMPULSE CONTROL; DISORDERS; PREVALENCE;
D O I
10.1016/j.parkreldis.2014.01.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To investigate hypomania and mania related to dopamine replacement therapy (DRT) in Parkinson's disease (PD). Methods: We recruited 108 non-demented PD patients without deep brain stimulation from a movement disorders in and outpatient clinic. Forty-five age- and gender-matched controls were also included. Disease characteristics, cognitive functioning, comorbid psychiatric diseases, dopaminergic and psychiatric medication were evaluated. Diagnosis of DRT-related hypomania and mania was based on DSM-IV-TR criteria with supplementary assessment of two mania self-rating scales. First, patients and controls were compared. Patients with DRT-related hypomania or mania were then compared to the remaining patients. A binary logistic regression analysis was performed to identify correlates of DRT-related hypomania. Results: Patients scored significantly higher on mania self-rating scales than controls. Twelve patients (11.1%) had DRT-related hypomania and six patients (5.6%) had DRT-related mania. Both groups had significantly higher self-rating mania-scores than patients without these mood states. DRT-related hypomania was significantly related to younger age, younger age at PD onset, dyskinesias, higher levodopa equivalent daily dose, dopamine dysregulation, and amantadine treatment. In contrast, DRT-related mania was significantly associated with hallucinations and delusions, history of levodopa-induced psychosis, quetiapine treatment, higher depression and daily levodopa dose, and cognitive deficits. Regression analysis revealed dopamine dysregulation, dyskinesias, amantadine treatment, and younger age at PD onset as significant correlates of DRT-related hypomania. Conclusion: DRT-related hypomania and mania are relevant comorbidities in PD. DRT-related hypomania may exist as a distinct psychiatric symptom complex in young patients with early disease onset. Different patient profiles likely underlie DRT-related hypomania and mania. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:421 / 427
页数:7
相关论文
共 50 条
  • [41] Impact of acute dopamine replacement on executive function in Parkinson's disease
    Mills, Kelly A.
    Pontone, Gregory M.
    Kamath, Vidya
    Perepezko, Kate
    Hinkle, Jared T.
    Morrow, Christopher
    Seemiller, Joseph
    MOVEMENT DISORDERS, 2023, 38 : S10 - S10
  • [42] Levodopa/dopamine replacement strategies in Parkinson's disease - Future directions
    Olanow, C. Warren
    MOVEMENT DISORDERS, 2008, 23 : S613 - S622
  • [43] Dyskinesias and dopamine cell replacement in Parkinson's disease: a clinical perspective
    Hagell, P
    Cenci, MA
    BRAIN RESEARCH BULLETIN, 2005, 68 (1-2) : 4 - 15
  • [44] Impaired stopping reversed through dopamine replacement in Parkinson's disease
    Choudhury, S.
    Roy, A.
    Singh, R.
    Chatterjee, K.
    Mondal, B.
    Baker, M.
    Baker, S.
    Kumar, H.
    MOVEMENT DISORDERS, 2018, 33 : S682 - S682
  • [45] The degeneration and replacement of dopamine cells in Parkinson's disease: the role of aging
    Rodriguez, Manuel
    Morales, Ingrid
    Rodriguez-Sabate, Clara
    Sanchez, Alberto
    Castro, Rafael
    Miguel Brito, Jose
    Sabate, Magdalena
    FRONTIERS IN NEUROANATOMY, 2014, 8
  • [46] Hormone replacement therapy and risk of Parkinson's disease
    Martignoni, E
    Nappi, RE
    Calandrella, D
    Zagaglia, R
    Sommacal, A
    Riboldazzi, G
    Polatti, F
    Pacchetti, C
    Nappi, G
    HORMONE REPLACEMENT THERAPY AND THE BRAIN: THE CURRENT STATUS OF RESEARCH AND PRACTICE, 2003, : 204 - 208
  • [47] Dopamine replacement influences on postural motor learning in Parkinson's disease
    Paul, S.
    Olivier, G.
    Walter, C.
    Schaefer, S.
    Dibble, L.
    MOVEMENT DISORDERS, 2017, 32
  • [48] Impact of Acute Dopamine Replacement on Cognitive Function in Parkinson's Disease
    Seemiller, Joseph
    Morrow, Christopher
    Hinkle, Jared T.
    Perepezko, Kate
    Kamath, Vidyulata
    Pontone, Gregory M.
    Mills, Kelly A.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2024, 11 (05): : 534 - 542
  • [49] Resting-State and Task-Related fMRI Correlates of Working Memory Performance in Parkinson's Disease, on and off Dopamine Replacement Therapy
    Simioni, Alison
    Dagher, Alain
    Fellows, Lesley
    NEUROLOGY, 2016, 86
  • [50] The effect of dopamine agonist therapy on dopamine transporter imaging in Parkinson's disease
    Ahlskog, JE
    Uitti, RJ
    O'Connor, MK
    Maraganore, DM
    Matsumoto, JY
    Stark, KF
    Turk, MF
    Burnett, OL
    MOVEMENT DISORDERS, 1999, 14 (06) : 940 - 946